Results of G004, a phase IIb study in recurrent glioblastoma patients with the TGF-b2 targeted compound AP 12009.

Bogdahn, U. and Oliushine, V. E. and Parfenov, V. E. and Kunst, M. and Mahapatra, A. and Sastry, K. V. and Venkataramana, K. N. and Jachimczak, P. and Hau, P. and Schlingensiepen, K. (2006) Results of G004, a phase IIb study in recurrent glioblastoma patients with the TGF-b2 targeted compound AP 12009. JOURNAL OF CLINICAL ONCOLOGY, 24 (18Supp). 71S. ISSN 0732-183X

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Neurologie
Depositing User: Petra Gürster
Date Deposited: 16 Feb 2021 08:28
Last Modified: 16 Feb 2021 08:28
URI: https://pred.uni-regensburg.de/id/eprint/34431

Actions (login required)

View Item View Item